This statement from Imagion Biosystems , when still under total control of MHTX, may help us out in that next leg up. Look and see one company who is among our competitors... "With respect to our nanomedicine technology, our cancer detection technology will face competition primarily from companies such as Abbott Laboratories Inc., Cepheid Inc., Philips, GE Healthcare, Siemens, Gen-Probe Incorporated, MDxHealth SA, EpiGenomics AG, Roche Diagnostics and Sequenom, Inc."
Expand
